Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier for advanced OPTIONS screeners and volatility tools. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Assembly Biosciences (ASMB)

Assembly Biosciences (ASMB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Assembly Biosciences TWO TOWER PLACE 7TH FLOOR SOUTH SAN FRANCISCO CA 94080 USA

www.assemblybio.com P: 833-509-4583

Description:

Assembly Biosciences, Inc. is a biopharmaceutical company. It develops therapies for infectious diseases and other disorders of the gastrointestinal (GI) system. Assembly's product portfolio consists of two late stage assets: VEN 307 for relief from pain associated with anal fissures and VEN 308 for the treatment of fecal incontinence. The Company is also developing novel microbiome-based technology for targeted oral delivery of therapeutic bacteria, complex proteins, viral antigens and small molecules to treat intractable infectious diseases of the GI tract, such as C. difficile infections. Assembly Biosciences Inc., formerly known as Ventrus Biosciences, Inc., is based in New York.

Key Statistics

Overview:

Market Capitalization, $K 86,559
Enterprise Value, $K 66,719
Shares Outstanding, K 5,513
Annual Sales, $ 7,160 K
Annual Net Income, $ -61,230 K
Last Quarter Sales, $ 5,790 K
Last Quarter Net Income, $ -9,080 K
EBIT, $ -62,980 K
EBITDA, $ -64,120 K
60-Month Beta 0.63
% of Insider Shareholders 5.10%
% of Institutional Shareholders 19.92%
Float, K 5,232
% Float 94.90%
Short Volume Ratio 0.30

Growth:

1-Year Return 20.03%
3-Year Return -64.35%
5-Year Return -91.09%
5-Year Revenue Growth -51.62%
5-Year Earnings Growth 72.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -1.66 on 05/08/24
Next Earnings Date 08/14/24
Earnings Per Share ttm -8.74
EPS Growth vs. Prev Year 62.63%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%
Most Recent Split 1-12 on 02/12/24

ASMB Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -120.58%
Return-on-Assets % -54.79%
Profit Margin % -855.17%
Debt/Equity 0.00
Price/Sales 12.04
Price/Cash Flow N/A
Price/Book 2.57
Book Value/Share 5.95
Interest Coverage -1.67
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar